FinTechFunding

Zelira Therapeutics: Launches Hope products in Australia

  • Zelira Therapeutics (ZLD) has launched its Hope products in Australia after receiving Therapeutic Goods Administration (TGA) approval
  • The two proprietary cannabinoid formulations, Hope 1 and Hope 2, were developed to support the needs of patients with Autism Spectrum Disorder
  • The Hope products were launched in the U.S. state of Pennsylvania last year and Louisiana in August this year
  • In August this year, the products were also launched in Louisiana, in partnership with Advanced Biomedics
  • The company has now launched five products in 2020
  • Following today’s announcement, Zelia shares are up 8.86 percent, priced at 8.6 cents at 10:48 am AEDT
Previous article
Accor & BNP Paribas: Become strategic partners
Next article
LiveTiles: Shares slip on latest quarterly update
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Italy Fines Revolut €1.15M for Regulatory Violations

Revolut faces penalties due to non-compliance with Italian financial regulations.Highlights: Italy fines Revolut €1.15 million for regulatory breaches.The...
FinTech

DeFi Platform Drift Suspends Withdrawals After Crypto Hack

Drift takes precautionary measures following security breach affecting user funds.Highlights: Drift has suspended all deposits and withdrawals after...
FinTech

Cross River Bank Raises $50 Million to Accelerate Growth

The funding will enhance Cross River Bank's financial technology services.Highlights: Cross River Bank has raised $50 million in...
FinTech

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...